Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what discussions he has had with NHS England on how the survival rates for pancreatic cancer are reflected in assessments of new treatments for that disease.
We have had no such discussions.
NHS England assesses new cancer drugs for inclusion on the national Cancer Drugs Fund (CDF) list in accordance with its CDF Standard Operating Procedures, which are available at:
www.england.nhs.uk/ourwork/pe/cdf/cdf-sop/